Ethyl 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylate, 98.0%, 100mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 2 - MWCO 12,000–14,000, 25 mm, 1 Piece(s)

(2-Mercapto-1,3,4,9-tetraaza-fluoren-9-yl)-acetic acid, 5g

4-BROMO-6-FLUORO-1H-INDAZOLE, 95%, 100mg

Bicyclo[3.3.1]nonan-9-one, 98%, 500mg

5,5'-Divinyl-2,2'-bipyridine, 97% (stabilized with TBC), 1g

3-(benzylamino)-1-propanol hydrochloride, 95.0%, 25g

Crizotinib, 95%, 50mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-leucine>98.0%(HPLC)(T)1g

(1-(Difluoromethyl)-1H-pyrazol-4-yl)boronic acid, 98+%, 250mg

1-Trifluoroacetyl piperidine, 97.0%, 5g

2-Bromo-5-nitro-1H-indole, 95.0%, 1g

2,4-Dichloro-6-phenyl-1,3,5-triazine>98.0%(GC)5g